Emerald Health (OTCMKTS:EMHTF) And Valens Groworks (OTCMKTS:VLNCF) Enter Multi-Year Extraction And White-Label Deal

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) has signed a multi-year cannabis extraction, and white label deal with Valens GroWorks Corp (OTCMKTS:VLNCF).

Emerald to supply 10,000kg annually to Valens for processing

The initial term of the agreement is four years, whereby Emerald will supply at least 10,000 kg of hemp biomass and cannabis per year to Valens. They will supply the product for processing through the exclusive extraction and processing methods of Valens on a fee for service basis.

Besides the extraction and processing services, Valens will also provide white-label services that include mixing, formulation as well as fixing for product formats. The product formats will encompass tinctures, vaporizers, and softgels. Valens has the required license to carry the obligations as indicated under the agreement, and Emerald is expecting to make the first shipment in the first quarter of 2020.

Valens GroWorks CEO, Tyler Robson, stated that they were delighted to partner with Emerald by providing their extraction processing and white label expertise to enhance their supply chain. He added that Emerald has a very important medical marijuana program in Canada, and they were looking forward to working together to help in scaling their operations and expanding their product portfolio.

Emerald Health seeks to exploit Valens’ proprietary fulfillment solution

Riaz Bandali, the CEO of Emerald, indicated that they were pleased to partner with Valens, and they look forward to introducing the products they will produce through the strategic partnership to the market. Bandali added that besides Valens being an industry leader in cannabis extraction, formulation as well as other services, its end-to-end fulfillment solution is cost-effective. As a result, this can help Emerald in transitioning its product ideas into the product in a cost-effective and faster way.

Recently Emerald gave its Pure Sunfarms joint venture $940,000. Thu is part of the agreement to pay around $25.0 million with the exercise of Pure Sunfarm’s acquisition of Delta 2 greenhouse. The company is planning to advance around $710,000 as part of the final payment in January 2020.


Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Provides Details About Its Latest Cultivation Expansion License

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) is pleased to receive the full municipal permitting for its properties in British Columbia. It looks forward to commencing its operations at two of its 78,000 square foot greenhouses. Health Canada has been reviewing the company and after realizing it had met the required conditions gave it the cultivation license amendment.

A close outlook

Emerald is currently staring at an additional license 50,000 square feet growing space, and some other seven grow areas. At the current state of affairs, the business guru can commence its operations at the site. In a statement, the company said it was making plans to kickstart its planting activities at the site. If all moves according to plan, the planting activities may reach completion by the end of Q4.Probably, the first harvest may be in January 2020.

The Chief Executive Officer of Emerald Riaz Bandali has spoken about the matter. He says that they look forward to starting the planting activities. According to the official, the Metro Vancouver organic operation will see the company move to new financial heights.

He also congratulated the company for its most recent achievement. He thinks that the licensing of the Québec premium craft product indoor cultivation site is a major step forward for them. Emerald Health Therapeutics seeks to produce industry-leading products in terms of quality, and it will make it happen in the Metro Vancouver site. The business giant says it will be counting on its extensive experience in production and compliance to make it in the dynamic markets. As always, product consumers in the market aspire to obtain premium organic products, and this is what the company is working towards.

Other major developments

Emerald Health Therapeutics has also spoken about the latest development regarding its wholly-owned production facility, Verdélite. The facility obtained a license amendment permitting from Health Canada. With this development, it seeks to focus on the sale and distribution of packaged, branded dried cannabis products. It will distribute the products to the authorized private retailers and territorial wholesalers. All the products being package by Verdélite are under the Emerald brand.

The other thing is that Emerald Health Therapeutics has distanced itself from certain terms reading its agreement with Pure Sunfarms Corp. It asserts that it doesn’t have any liability in the deal. Pure Sunfarms Corp happens to be Emerald’s 50%-owned joint venture, and the exchanges are in line with the current Supply Agreement between the two. The company is not happy with the way the joint venture conducted the Supply Agreement.


Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Offers Ultra Pure CBD Oil To The Consumers In British Columbia

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) has launched ultra pure sync 25 CBD oil to fill the recreational space in British Columbia. It is a smoke-free and non-THC alternative to the consumers.

Emerald has sent 6,000 40 ml units of Sync 25 CBD oil to BCLDB (British Columbia Liquor Distribution Branch). Executive Chairman and President of Emerald, Dr. Avtar Dhillon said the company is pleased to introduce wellness product SYNC 25 under its brand to fill the gap in the recreational market of British Columbia.

Extraction of SYNC 25 CBD oil

The new product launch is part of Emerald’s growth strategy, and to enjoy higher profit margins through developing quality and innovative products. Medipharm Labs Inc extracts the SYNC 25 CBD oil for Emerald.

CEO of Medipharm, Pat McCutcheon said the company’s expertise in extracting the SYNC 25 CBD oil complements the success of Emerald to introduce the product to meet the growing demand. The company will strive to supply high-quality cannabis concentrates on supporting the expansion plans of Emerald. SYNC 25 CBD oil is available online for immediate purchase.

Appointment of Chief Operating Officer

Emerald has posted Sean Rathbone as COO. He will contribute expertise in technology advancement, corporate process management, operational leadership, raw materials refinement, and waste reduction.

Executive Chairman said Rathbone is an industrial engineer and brings experience in promoting the growth of operational mandate on a large scale. Rathbone will play a vital role in introducing technologies, processes, and policies to achieve the production targets as Emerald continues on an expansion spree to satisfy the growing demand for cannabis products in Canada. He will ensure operational efficiencies and maintain performance standards companywide.

Rathbone has played the role of Vice President (Production), Western Canada at Agropur. He also worked as a Manager (Manufacturing R&D) BDO Canada LLP.

Standard processing license

Health Canada has awarded standard processing license to Pure Sunfarms for 1.1 million sq. Ft Delta 3 Greenhouse facility. The license allows Pure Sunfarms the extraction and processing of cannabis at Delta 3 Greenhouse facility. Emerald holds a stake of 50% in the joint venture: Pure Sunfarms, which requires an amended sales license to market cannabis oil.


Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Supplies Cannabis To Yukon Liquor Corporation And Seals Supply Accords With Saskatchewan And Alberta

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) completed the supply of cannabis Yukon Liquor Corporation fulfilling the first purchase order. The company also inked supply accords with Saskatchewan Liquor and Gaming Authority and Alberta Gaming, Liquor, and Cannabis. The company is expected to begin shipments of cannabis to Saskatchewan and Alberta in April 2019.

Executive Chairman and President of Emerald, Dr. Avtar Dhillon said the company is pleased to supply Emerald branded cannabis products for adult use Saskatchewan and Alberta and Yukon. With the latest supply accords, the company supplies cannabis products to one territory and five provinces in Canada and becomes a reliable supplier for recreational use.

Consistent Supply

As per the latest reports, Emerald is fulfilling the supply of cannabis in time in Labrador, Newfoundland, British Columbia, and Ontario. To increase the footprint, the company is exploring supply accords for recreational use of cannabis in other provinces.

Cannabis from Verdélite indoor facility

The company is fulfilling the cannabis supply from Pure Sunfarms and Verdélite indoor facility based in Saint Eustache, Québec. Emerald owns 50% stake in Pure Sunfarms, which has obtained a license to cultivate cannabis on 1.03 million Sq. ft. The company is putting in efforts to expand the production of cannabis by enhancing volume of outdoor, indoor and greenhouse grown cannabis. It also purchased harvested hemp on 500 acres in 2018. Emerald is planning to acquire additional harvested hemp on 1000 acres in 2019.

ATM Program for working capital

Emerald established an ATM Program (At-The-Market Equity Program) to mobilize funds of up to $39 million by issuing common shares. The ATM Program will be effective up to April 13, 2021. The company will activate this program when a need arises for capital expenditure and working capital.

Emerald applauded the proposed amendment in excise tax calculation in the federal budget for cannabis. The proposed revision allows computing excise duty for hemp and ingestible cannabis products considering THC quantity than based on volume of the products. It also paves for lower tax on products with low THC content. Therefore, the proposed amendment offers additional tax relief for medical use of cannabis by individuals. Emerald is expected to improve margins on medical cannabis products.


Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Holds A Stake of 51% In Newly Formed JV Emerald Health Naturals

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) (Emerald) together with Emerald Health Bioceuticals (EHB) formed a joint venture called Emerald Health Naturals (EHN). Emerald and EHB hold stakes of 51% and 49% in the newly established JV. Emerald invested $5 million in EHN. The JV received exclusive rights in Canada for the distribution of EHB products.

Product line of EHB

The product portfolio of EHB comprises nutritional supplements, which are developed using non-psychoactive and non-cannabis plant-derived bioactive compounds. The nutritional supplements help to support the endocannabinoid system of a human body.

According to market research, around 60% of the legal cannabis users use natural health products. Emerald uses this excellent opportunity to develop its health brand with the help of EHN. The company will sell the products, which support the endocannabinoid system, through natural health product channels. The federal regulations for recreational use in Canada, which came into force on October 17, 2018, do not allow these channels to sell cannabis products. However, the company is well poised to launch cannabis products through these channels if the regulatory environment permits the same in the future.

GAB Innovations sells assets to EHN

GAB Innovations sold its assets to EHN. Avricore Pharmaceuticals received non-exclusive sub-distribution rights from EHN. Avricore and GAB are successful players in the sale of natural health products. EHN recruited founder of GAB, Gaetano Morello as the Chief Executive Officer of EHN. EHN recruited founder of GAB, Gaetano Morello as the Chief Executive Officer of EHN. Chris Wagner is stepped down from the CEO post of Emerald. However, he will continue to provide consultancy services to the company.

Emerald fulfilled the supply commitments to the cannabis distribution customers in the province during Q3 2018. The company demonstrated its ability to supply cannabis for the adult channel. President of Emerlad, Avtar Dhillon said the company would scale up the commercial production and sales in Q4 2018 with hemp sourcing agreements, Quebec facility, and Pure Sunfarms JV. These raw materials would help to augment its alliance with Factors Group.

Emerald filed applications, which covers cannabis formulations and dosage, for multiple provisional patents in the US. It allows the adult use and medical use consumers to the desired results using proven and reliable products.


Health Canada Awards Cannabis Sales License to the JV of Village Farms International Inc (OTCMKTS:VFFIF) and Emerald Health Therapeutics Inc (OTCMKTS:EMHTF)

Pure Sunfarms, a JV of Village Farms International Inc (OTCMKTS:VFFIF) and Emerald Health Therapeutics Inc (OTCMKTS:EMHTF), has got the cannabis sales license from the Health Canada.

The JV can now sell the good quality dried cannabis to Emerald Health Therapeutics. Pure Sunfarms can also meet the demand for this product from various licensed manufacturers. The sales license also allows the company to enter into supply accords with government distributors for adult use.

Chief Executive Officer of Village Farms International Inc., Michael DeGiglio said Pure Sunfarms is meeting the supply schedules. The company has transformed into selling the cannabis from the cultivation and sale of tomatoes in just 7 months.

The Joint Venture is planning to expand the capacity and maximize the profits when cannabis for adult use is expected to be legalized on October 17, 2018, in Canada. The company intends to capitalize on the short supply during the initial period of legalization.

Pure Sunfarms is planning to go ahead aggressively with the strategy of branding and product development.

Chief Executive Officer of Emerald Health Therapeutics Inc has stated that the JV is proceeding at a rapid pace to become a high volume and good quality cannabis supplier. The company has been able to quickly turnaround with the timely response from Health Canada.

The JV is expected to further boost sales in the coming quarters with expected sales accords with provincial governments and wholesalers. It will improve the value for both Village Farms International Inc. and Emerald Health Therapeutics Inc.

Pure Sunfarms to Find Place in Top Licensed Cannabis Producers in Canada

Pure Sunfarms is expected to find a place in the top tier cannabis producers in 2018 and 2019.

Village Farms International Inc. and Emerald Health Therapeutics Inc hold 50: 50 stake in Pure Sunfarms.

Brief Information about Village Farms International Inc

North America based greenhouse producers – Village Farms International Inc has mastered the growing. It has environment friendly growing practices and advanced technologies to produce and distribute high quality products throughout the year.

Brief Information about Emerald Health Therapeutics Inc

Emerald Health Therapeutics Inc is engaged in the sale of cannabis oil and dried cannabis for medical use.

Pin It on Pinterest